X-25013536-GGCGGCC-GGCGGCCGCGGCC
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The ENST00000379044.5(ARX):c.458_459insGGCCGC(p.Ala154_Ala155dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000259 in 811,267 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000048 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000023 ( 0 hom. 5 hem. )
Consequence
ARX
ENST00000379044.5 inframe_insertion
ENST00000379044.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in ENST00000379044.5.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARX | NM_139058.3 | c.458_459insGGCCGC | p.Ala154_Ala155dup | inframe_insertion | 2/5 | ENST00000379044.5 | NP_620689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARX | ENST00000379044.5 | c.458_459insGGCCGC | p.Ala154_Ala155dup | inframe_insertion | 2/5 | 1 | NM_139058.3 | ENSP00000368332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000478 AC: 5AN: 104588Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 29912
GnomAD3 genomes
AF:
AC:
5
AN:
104588
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
29912
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000226 AC: 16AN: 706679Hom.: 0 Cov.: 31 AF XY: 0.0000233 AC XY: 5AN XY: 214469
GnomAD4 exome
AF:
AC:
16
AN:
706679
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
214469
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000478 AC: 5AN: 104588Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 29912
GnomAD4 genome
AF:
AC:
5
AN:
104588
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
29912
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2024 | Alanine repeat expansion in the second polyalanine tract of the ARX protein, extending the allele to 14 repeats; Polyalanine repeat expansions of 12 or fewer repeats have been observed in unaffected adult males undergoing testing at GeneDx; Polyalanine repeat expansions of 13-19 repeats have not been previously reported in the literature, to our knowledge (HGMD) - |
Uncertain significance, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Sep 26, 2013 | - - |
Intellectual disability, X-linked, with or without seizures, arx-related;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This variant, c.453_458dup, results in the insertion of 2 amino acid(s) of the ARX protein (p.Ala154_Ala155dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ARX-related conditions. ClinVar contains an entry for this variant (Variation ID: 96456). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at